Researchers at Cedars-Sinai Heart Institute have developed a minimally invasive gene transplant procedure that changes heart muscle cells into cells that act like a pacemaker to keep the heart beating properly. Scientists say the procedure, currently being tested on animals, could be ready for clinical studies on people in about three years. CBS News' Bigad Shaban reports.
